Dr. Luis Diaz Jr., an oncologist at Memorial Sloan Kettering Cancer Center, led a 2022 clinical trial of MMR-deficient rectal cancer with a 100% success rate.
My namesake aunt died in her 30s from colorectal cancer, a once rare occurrence. Now people in their 20s, 30s, and 40s are getting this disease, so I asked experts why this is happening and what people like me can do about it.
As the development of systemic treatments for metastatic colorectal cancer move toward precision therapy, guidelines have adjusted to integrate decisions based on molecular drivers.
My namesake aunt died in her 30s from colorectal cancer, a once rare occurrence. Now people in their 20s, 30s, and 40s are getting this disease, so I asked experts why this is happening and what people like me can do about it.